NCT01303341 2026-04-13
Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
10 trialsNCT07447050 2026-03-03
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
University of California, Irvine
Phase 2 Recruiting
NCT06580002 2025-06-26
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
University of California, Irvine
Phase 2 Recruiting
NCT03722680 2025-04-23
RILUZOX-01
UNICANCER
Phase 2 Suspended
NCT04761614 2025-03-28
Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT00866840 2024-01-19
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT02796755 2021-04-14
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
Emory University
Phase 4 Completed
NCT01018836 2014-05-02
Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Rutgers, The State University of New Jersey
Phase 1 Terminated
NCT00903214 2013-04-29
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn
NCT00667901 2009-12-11
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Rutgers, The State University of New Jersey
Phase 1 Terminated